デフォルト表紙
市場調査レポート
商品コード
1553464

プラスミド精製の市場規模、シェア、動向分析レポート:製品・サービス別、グレード別、用途別、最終用途別、地域別、セグメント別予測、2024年~2030年

Plasmid Purification Market Size, Share & Trends Analysis Report By Product & Service (Kits & Reagents, Instruments), By Grade (Molecular Grade, Transfection Grade), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030


出版日
ページ情報
英文 120 Pages
納期
2~10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
プラスミド精製の市場規模、シェア、動向分析レポート:製品・サービス別、グレード別、用途別、最終用途別、地域別、セグメント別予測、2024年~2030年
出版日: 2024年08月14日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

プラスミド精製市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、世界のプラスミド精製市場規模は2030年までに36億9,000万米ドルに達すると予測され、2024年から2030年までのCAGRは11.60%で成長すると予測されています。

細胞・遺伝子治療の受け入れ拡大や組換え技術製品の需要増加が市場成長の要因です。さらに、プラスミド精製の技術進歩が市場成長をさらに促進します。

プラスミドは遺伝子治療と遺伝子医療において極めて重要です。そのユニークな特性により、治療用遺伝子を標的細胞に導入するための効果的なベクターとして機能します。プラスミドは、病気の原因となる欠陥遺伝子を修正したり置き換えたりするために、特定の細胞に外来遺伝子を導入することで機能します。さらに、様々な疾患の治療のために遺伝子治療が受け入れられ、応用されるようになるにつれて、精製されたプラスミドDNAの必要性が高まっています。遺伝子治療では、プラスミドは治療遺伝子を送達するためのベクターとして機能します。

研究者は、変異した遺伝子の正常コピー、病気と闘うためのタンパク質をコードする遺伝子、あるいは有害な遺伝子を沈黙させるshRNAのようなRNA分子など、治療用遺伝子を運ぶプラスミドをデザインします。プラスミドの精製は、遺伝子治療の開発と応用において極めて重要です。染色体DNA、タンパク質、エンドトキシン、残留細菌成分などの汚染物質は、治療製品の有効性と安全性を妨げる可能性があります。従って、精製技術の進歩はプラスミドDNAの収量と品質を向上させ、プラスミド生産のスケーラビリティを促進します。

COVID-19パンデミックは市場成長に大きな影響を与えています。COVID-19ワクチンと治療に対する緊急の必要性に後押しされた合成生物学製品に対する需要の増加は、クローニング技術の研究開発(R&D)を加速させています。このような合成生物学における研究開発活動の急増は、ワクチン開発、診断、治療研究に携わる企業への資金提供や投資の増加につながっています。さらに、パンデミックによってもたらされた課題にもかかわらず、新規技術の採用が増加していること、遺伝子治療に対する需要が高まっていること、遺伝子工学の進歩が続いていることなどから、市場は安定した成長を続けると予想されます。

しかし、組換えDNA技術の使用に関連する倫理的制約は、生物兵器を開発するための合成生物学技術を通じて有害な病原体を作り出す際に、遺伝子クローニングと合成技術が悪用されることが市場の主な懸念事項の一つです。合成DNAやプラスミドの不適切な取り扱いや廃棄は、環境汚染につながる可能性があります。環境に放出された人工生物は生態系に影響を及ぼす可能性があります。

プラスミド精製市場レポート・ハイライト

  • 専用キットや試薬の使用により、精製プロセスの効率、信頼性、品質が大幅に向上するため、2023年には製品分野が72.93%の最大収益シェアで市場をリードしました。さらに、サービス分野は2024年から2030年にかけて12.58%の大幅なCAGRが見込まれます。
  • グレード別では、分子グレードセグメントが2023年に58.42%の最大売上シェアで市場をリードしました。これは、これらのプラスミドが容易に操作・改変できるように設計されており、研究者が遺伝物質に正確な変更を加えることができるためです。トランスフェクショングレードセグメントは、予測期間中に13.24%のCAGRで最も急速に成長すると予測されています。
  • 用途別では、遺伝子組み換え作物や生物に対する需要の高まりにより、クローニング&タンパク質分野が2023年に48.76%の最大収益シェアで市場をリードしました。さらに、トランスフェクション&遺伝子編集セグメントは、予測期間中に最も速いCAGRで成長すると予測されています。
  • 最終用途に基づくと、学術・研究機関セグメントは2023年に40.12%の最大収益シェアで市場をリードしました。これは、新規遺伝子治療や遺伝子操作されたバイオテクノロジー製品を市場に投入するための研究開発への多大な貢献によるものです。また、委託研究機関セグメントは、高度な研究・製造技術への採用や投資が増加していることから、予測期間中に13.38%のCAGRで最も急速に拡大すると予測されています。
  • 北米は、研究開発活動への投資の増加、個別化医療への需要の高まり、高度なバイオテクノロジー研究インフラなどの要因により、2023年には40.58%の最大収益シェアで市場を独占しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 プラスミド精製市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • プラスミド精製市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析
    • COVID-19の影響分析

第4章 プラスミド精製市場:製品・サービス別推定・動向分析

  • セグメントダッシュボード
  • 世界のプラスミド精製市場の製品・サービス別変動分析
  • 世界のプラスミド精製市場の規模と動向分析、製品・サービス別、2018年から2030年
  • 製品
  • サービス

第5章 プラスミド精製市場:グレード別推定・動向分析

  • セグメントダッシュボード
  • 世界のプラスミド精製市場の変動分析
  • 世界のプラスミド精製市場の規模と動向分析、グレード別、2018~2030年
  • 分子グレード
  • トランスフェクショングレード

第6章 プラスミド精製市場:用途別推定・動向分析

  • セグメントダッシュボード
  • 世界のプラスミド精製市場の用途別変動分析
  • 世界のプラスミド精製市場の規模と動向分析、用途別、2018~2030年
  • クローニングとタンパク質発現
    • 市場推計・予測、2018年から2030年
  • トランスフェクションと遺伝子編集
    • 市場推計・予測、2018年から2030年
  • その他
    • 市場推計・予測、2018年から2030年

第7章 プラスミド精製市場:最終用途別推定・動向分析

  • セグメントダッシュボード
  • 世界のプラスミド精製市場の最終用途別変動分析
  • 世界のプラスミド精製市場の規模と動向分析、最終用途別、2018~2030年
  • 製薬・バイオテクノロジー企業
  • 学術研究機関
  • 受託研究機関

第8章 プラスミド精製市場:地域別推定・動向分析

  • 地域別市場シェア分析、2023年および2030年
  • 地域市場ダッシュボード
  • 北米
    • 北米市場推計・予測、2018年から2030年
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 欧州市場推計・予測、2018年から2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • アジア太平洋市場推計・予測、2018年から2030年
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ラテンアメリカ市場推計・予測、2018年から2030年
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 中東・アフリカ市場推計・予測、2018年から2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第9章 競合情勢

  • 企業/競合の分類
  • 戦略マッピング
  • 企業市況分析、2023年
  • 企業プロファイル/上場企業
    • Merck KGaA
    • QIAGEN
    • Thermo Fisher Scientific, Inc.
    • Takara Bio
    • Promega Corporation
    • Zymo Research
    • MP BIOMEDICALS
    • New England Biolabs
    • MCLAB
    • Applied Biological Materials, Inc.
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global plasmid purification market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global plasmid purification market, by product & service, 2018 - 2030 (USD Million)
  • Table 4 Global plasmid purification market, by grade, 2018 - 2030 (USD Million)
  • Table 5 Global plasmid purification market, by application, 2018 - 2030 (USD Million)
  • Table 6 Global plasmid purification market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 North America plasmid purification market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America plasmid purification market, by product & service, 2018 - 2030 (USD Million)
  • Table 9 North America plasmid purification market, by grade, 2018 - 2030 (USD Million)
  • Table 10 North America plasmid purification market, by application, 2018 - 2030 (USD Million)
  • Table 11 North America plasmid purification market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 U.S. plasmid purification market, by product & service, 2018 - 2030 (USD Million)
  • Table 13 U.S. plasmid purification market, by grade, 2018 - 2030 (USD Million)
  • Table 14 U.S. plasmid purification market, by application, 2018 - 2030 (USD Million)
  • Table 15 U.S. plasmid purification market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Canada plasmid purification market, by product & service, 2018 - 2030 (USD Million)
  • Table 17 Canada plasmid purification market, by grade, 2018 - 2030 (USD Million)
  • Table 18 Canada plasmid purification market, by application, 2018 - 2030 (USD Million)
  • Table 19 Canada plasmid purification market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Mexico plasmid purification market, by product & service, 2018 - 2030 (USD Million)
  • Table 21 Mexico plasmid purification market, by grade, 2018 - 2030 (USD Million)
  • Table 22 Mexico plasmid purification market, by application, 2018 - 2030 (USD Million)
  • Table 23 Mexico plasmid purification market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Europe plasmid purification market, by country, 2018 - 2030 (USD Million)
  • Table 25 Europe plasmid purification market, by product & service, 2018 - 2030 (USD Million)
  • Table 26 Europe plasmid purification market, by grade, 2018 - 2030 (USD Million)
  • Table 27 Europe plasmid purification market, by application, 2018 - 2030 (USD Million)
  • Table 28 Europe plasmid purification market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 UK plasmid purification market, by product & service, 2018 - 2030 (USD Million)
  • Table 30 UK plasmid purification market, by grade, 2018 - 2030 (USD Million)
  • Table 31 UK plasmid purification market, by application, 2018 - 2030 (USD Million)
  • Table 32 UK plasmid purification market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 Germany plasmid purification market, by product & service, 2018 - 2030 (USD Million)
  • Table 34 Germany plasmid purification market, by grade, 2018 - 2030 (USD Million)
  • Table 35 Germany plasmid purification market, by application, 2018 - 2030 (USD Million)
  • Table 36 Germany plasmid purification market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 France plasmid purification market, by product & service, 2018 - 2030 (USD Million)
  • Table 38 France plasmid purification market, by grade, 2018 - 2030 (USD Million)
  • Table 39 France plasmid purification market, by application, 2018 - 2030 (USD Million)
  • Table 40 France plasmid purification market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Italy plasmid purification market, by product & service, 2018 - 2030 (USD Million)
  • Table 42 Italy plasmid purification market, by grade, 2018 - 2030 (USD Million)
  • Table 43 Italy plasmid purification market, by application, 2018 - 2030 (USD Million)
  • Table 44 Italy plasmid purification market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 Spain plasmid purification market, by product & service, 2018 - 2030 (USD Million)
  • Table 46 Spain plasmid purification market, by grade, 2018 - 2030 (USD Million)
  • Table 47 Spain plasmid purification market, by application, 2018 - 2030 (USD Million)
  • Table 48 Spain plasmid purification market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Denmark plasmid purification market, by product & service, 2018 - 2030 (USD Million)
  • Table 50 Denmark plasmid purification market, by grade, 2018 - 2030 (USD Million)
  • Table 51 Denmark plasmid purification market, by application, 2018 - 2030 (USD Million)
  • Table 52 Denmark plasmid purification market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Sweden plasmid purification market, by product & service, 2018 - 2030 (USD Million)
  • Table 54 Sweden plasmid purification market, by grade, 2018 - 2030 (USD Million)
  • Table 55 Sweden plasmid purification market, by application, 2018 - 2030 (USD Million)
  • Table 56 Sweden plasmid purification market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Norway plasmid purification market, by product & service, 2018 - 2030 (USD Million)
  • Table 58 Norway plasmid purification market, by grade, 2018 - 2030 (USD Million)
  • Table 59 Norway plasmid purification market, by application, 2018 - 2030 (USD Million)
  • Table 60 Norway plasmid purification market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific plasmid purification market, by country, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific plasmid purification market, by product & service, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific plasmid purification market, by grade, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific plasmid purification market, by application, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific plasmid purification market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 China plasmid purification market, by product & service, 2018 - 2030 (USD Million)
  • Table 67 China plasmid purification market, by grade, 2018 - 2030 (USD Million)
  • Table 68 China plasmid purification market, by application, 2018 - 2030 (USD Million)
  • Table 69 China plasmid purification market, by end-use, 2018 - 2030 (USD Million)
  • Table 70 Japan plasmid purification market, by product & service, 2018 - 2030 (USD Million)
  • Table 71 Japan plasmid purification market, by grade, 2018 - 2030 (USD Million)
  • Table 72 Japan plasmid purification market, by application, 2018 - 2030 (USD Million)
  • Table 73 Japan plasmid purification market, by end-use, 2018 - 2030 (USD Million)
  • Table 74 India plasmid purification market, by product & service, 2018 - 2030 (USD Million)
  • Table 75 India plasmid purification market, by grade, 2018 - 2030 (USD Million)
  • Table 76 India plasmid purification market, by application, 2018 - 2030 (USD Million)
  • Table 77 India plasmid purification market, by end-use, 2018 - 2030 (USD Million)
  • Table 78 South Korea plasmid purification market, by product & service, 2018 - 2030 (USD Million)
  • Table 79 South Korea plasmid purification market, by grade, 2018 - 2030 (USD Million)
  • Table 80 South Korea plasmid purification market, by application, 2018 - 2030 (USD Million)
  • Table 81 South Korea plasmid purification market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 Australia plasmid purification market, by product & service, 2018 - 2030 (USD Million)
  • Table 83 Australia plasmid purification market, by grade, 2018 - 2030 (USD Million)
  • Table 84 Australia plasmid purification market, by application, 2018 - 2030 (USD Million)
  • Table 85 Australia plasmid purification market, by end-use, 2018 - 2030 (USD Million)
  • Table 86 Thailand plasmid purification market, by product & service, 2018 - 2030 (USD Million)
  • Table 87 Thailand plasmid purification market, by grade, 2018 - 2030 (USD Million)
  • Table 88 Thailand plasmid purification market, by application, 2018 - 2030 (USD Million)
  • Table 89 Thailand plasmid purification market, by end-use, 2018 - 2030 (USD Million)
  • Table 90 Latin America plasmid purification market, by country, 2018 - 2030 (USD Million)
  • Table 91 Latin America plasmid purification market, by product & service, 2018 - 2030 (USD Million)
  • Table 92 Latin America plasmid purification market, by grade, 2018 - 2030 (USD Million)
  • Table 93 Latin America plasmid purification market, by application, 2018 - 2030 (USD Million)
  • Table 94 Latin America plasmid purification market, by end-use, 2018 - 2030 (USD Million)
  • Table 95 Brazil plasmid purification market, by product & service, 2018 - 2030 (USD Million)
  • Table 96 Brazil plasmid purification market, by grade, 2018 - 2030 (USD Million)
  • Table 97 Brazil plasmid purification market, by application, 2018 - 2030 (USD Million)
  • Table 98 Brazil plasmid purification market, by end-use, 2018 - 2030 (USD Million)
  • Table 99 Argentina plasmid purification market, by product & service, 2018 - 2030 (USD Million)
  • Table 100 Argentina plasmid purification market, by grade, 2018 - 2030 (USD Million)
  • Table 101 Argentina plasmid purification market, by application, 2018 - 2030 (USD Million)
  • Table 102 Argentina plasmid purification market, by end-use, 2018 - 2030 (USD Million)
  • Table 103 MEA plasmid purification market, by country, 2018 - 2030 (USD Million)
  • Table 104 MEA plasmid purification market, by product & service, 2018 - 2030 (USD Million)
  • Table 105 MEA plasmid purification market, by grade, 2018 - 2030 (USD Million)
  • Table 106 MEA plasmid purification market, by application, 2018 - 2030 (USD Million)
  • Table 107 MEA plasmid purification market, by end-use, 2018 - 2030 (USD Million)
  • Table 108 South Africa plasmid purification market, by product & service, 2018 - 2030 (USD Million)
  • Table 109 South Africa plasmid purification market, by grade, 2018 - 2030 (USD Million)
  • Table 110 South Africa plasmid purification market, by application, 2018 - 2030 (USD Million)
  • Table 111 South Africa plasmid purification market, by end-use, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia plasmid purification market, by product & service, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia plasmid purification market, by grade, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia plasmid purification market, by application, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia plasmid purification market, by end-use, 2018 - 2030 (USD Million)
  • Table 116 UAE plasmid purification market, by product & service, 2018 - 2030 (USD Million)
  • Table 117 UAE plasmid purification market, by grade, 2018 - 2030 (USD Million)
  • Table 118 UAE plasmid purification market, by application, 2018 - 2030 (USD Million)
  • Table 119 UAE plasmid purification market, by end-use, 2018 - 2030 (USD Million)
  • Table 120 Kuwait plasmid purification market, by product & service, 2018 - 2030 (USD Million)
  • Table 121 Kuwait plasmid purification market, by grade, 2018 - 2030 (USD Million)
  • Table 122 Kuwait plasmid purification market, by application, 2018 - 2030 (USD Million)
  • Table 123 Kuwait plasmid purification market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Plasmid purification market: Market outlook
  • Fig. 5 Plasmid purification market: Segment outlook
  • Fig. 6 Plasmid purification market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Plasmid purification market driver impact
  • Fig. 9 Plasmid purification market restraint impact
  • Fig. 10 Plasmid purification market: Product & service outlook and key takeaways
  • Fig. 11 Plasmid purification market: Product & service movement analysis
  • Fig. 12 Products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 13 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 Kits & reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Plasmid purification market: Grade outlook and key takeaways
  • Fig. 17 Plasmid purification market: Grade movement analysis
  • Fig. 18 Molecular-grade market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Transfection grade market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Plasmid purification market: Application outlook and key takeaways
  • Fig. 21 Plasmid purification market: Application movement analysis
  • Fig. 22 Cloning & protein expression market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Transfection & gene editing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Plasmid purification market: End use outlook and key takeaways
  • Fig. 26 Plasmid purification market: End use movement analysis
  • Fig. 27 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Academic & research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Contract research organizations market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Global plasmid purification market: Regional outlook and key takeaways
  • Fig. 31 Global plasmid purification market: Regional movement analysis
  • Fig. 32 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Key country dynamics
  • Fig. 34 US market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Key country dynamics
  • Fig. 36 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Key country dynamics
  • Fig. 41 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Key country dynamics
  • Fig. 43 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68040-413-9

Plasmid Purification Market Growth & Trends:

The global plasmid purification market size is anticipated to reach USD 3.69 billion by 2030 and is projected to grow at a CAGR of 11.60% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising acceptance of cell & gene therapy and growing demand for recombinant technology products are factors contributing to market growth. Moreover, technological advancements in plasmid purification further propel market growth.

Plasmids are crucial in gene therapy and genetic medicine. Their unique properties allow them to serve as effective vectors for delivering therapeutic genes into target cells. Plasmids function by introducing exogenous genes into specific cells to correct or replace defective genes responsible for diseases. Moreover, with the increasing acceptance and application of gene therapy for treating various diseases, there is a growing need for purified plasmid DNA. In gene therapy, plasmids serve as vectors for delivering therapeutic genes.

Researchers design plasmids to carry therapeutic genes, including normal copies of mutated genes, genes encoding proteins to combat disease, or RNA molecules like shRNA that can silence harmful genes. Plasmid purification is critical in the development and application of gene therapy. Contaminants such as chromosomal DNA, proteins, endotoxins, and residual bacterial components can interfere with the efficacy and safety of the therapeutic product. Thus, advancements in purification technologies enhance the yield and quality of plasmid DNA, facilitating the scalability of plasmid production, which is essential for meeting the increasing demands of gene therapy development.

The COVID-19 pandemic has significantly impacted the market growth. The increased demand for synthetic biology products, driven by the urgent need for COVID-19 vaccines and treatments, has accelerated research and development (R&D) in cloning technology. This surge in R&D activities in synthetic biology has led to increased funding and investment in companies involved in vaccine development, diagnostics, and therapeutic research. Moreover, despite the challenges posed by the pandemic, the market is expected to continue growing steadily due to the increasing adoption of novel technologies, the rising demand for gene therapies, and ongoing advancements in genetic engineering.

However, one of the primary concerns of the market is the ethical constraints related to the use of recombinant DNA technology is the misuse of gene cloning and synthesis technology in the creation of harmful pathogens through synthetic biology techniques to develop bioweapons. Improper handling or disposal of synthetic DNA and plasmids could lead to environmental contamination. Engineered organisms released into the environment could have ecological consequences.

Plasmid Purification Market Report Highlights:

  • The products segment led the market with the largest revenue share of 72.93% in 2023, as the use of specialized kits and reagents significantly enhances the efficiency, reliability, and quality of the purification process. Furthermore, the services segment is anticipated to experience at a significant CAGR of 12.58% from 2024 to 2030
  • Based on grade, the molecular grade segment led the market with the largest revenue share of 58.42% in 2023, as these plasmids are engineered to be easily manipulated and modified, allowing researchers to make precise changes to the genetic material. The transfection grade segment is anticipated to grow at the fastest CAGR of 13.24% over the forecast period
  • Based on application, the cloning & protein segment led the market with the largest revenue share of 48.76% in 2023, owing to the growing demand for genetically modified crops and organisms. Furthermore, the transfection & gene editing segment is expected to grow at the fastest CAGR over the forecast period.
  • Based on end use, the academic & research institutes segment led the market with the largest revenue share of 40.12% in 2023, driven by their significant contribution to R&D to bring novel gene therapy treatments and engineered biotechnological products to market. Also, the contract research organizations segment is expected to expand at the fastest CAGR of 13.38% during the forecast period, due to their increasing adoption and investment in advanced research and manufacturing technologies
  • North America dominated the market with the largest revenue share of 40.58% in 2023, owing to factors such as increasing investments in R&D activities, rising demand for personalized medicine, and advanced biotechnology research infrastructure

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product & Service Segment
    • 1.2.2. Grade Segment
    • 1.2.3. Application Segment
    • 1.2.4. End Use Segment
  • 1.3. Information Analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data Validation & Publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Plasmid Purification Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing demand for recombinant DNA technology (rDNA) products
      • 3.2.1.2. Technological advancements in plasmid purification
      • 3.2.1.3. Increasing adoption of cell and gene therapies
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Ethical constraints related to the use of rDNA technology
  • 3.3. Plasmid Purification Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Plasmid Purification Market: Product & Service Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Plasmid Purification Market Product & Service Movement Analysis
  • 4.3. Global Plasmid Purification Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
  • 4.4. Products
    • 4.4.1. Products market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Instruments
      • 4.4.2.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Kits & Reagents
      • 4.4.3.1. Kits & reagents market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Services
    • 4.5.1. Services market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Plasmid Purification Market: Grade Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Plasmid Purification Market Grade Movement Analysis
  • 5.3. Global Plasmid Purification Market Size & Trend Analysis, by Grade, 2018 to 2030 (USD Million)
  • 5.4. Molecular Grade
    • 5.4.1. Molecular-grade market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Transfection Grade
    • 5.5.1. Transfection grade market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Plasmid Purification Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Plasmid Purification Market Application Movement Analysis
  • 6.3. Global Plasmid Purification Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 6.4. Cloning & Protein Expression
    • 6.4.1. Cloning & protein expression market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Transfection & Gene Editing
    • 6.5.1. Transfection & gene editing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Plasmid Purification Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Plasmid Purification Market End Use Movement Analysis
  • 7.3. Global Plasmid Purification Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Pharmaceutical & Biotechnology Companies
    • 7.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Academic & Research Institutes
    • 7.5.1. Academic & research institutes market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6. Contract Research Organizations
    • 7.6.1. Contract research organizations market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Plasmid Purification Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2023 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. North America
    • 8.3.1. North America market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Competitive scenario
      • 8.3.2.3. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Competitive scenario
      • 8.3.3.3. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key country dynamics
      • 8.3.4.2. Competitive scenario
      • 8.3.4.3. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Competitive scenario
      • 8.4.2.3. UK market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Competitive scenario
      • 8.4.3.3. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Competitive scenario
      • 8.4.4.3. France market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key country dynamics
      • 8.4.5.2. Competitive scenario
      • 8.4.5.3. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key country dynamics
      • 8.4.6.2. Competitive scenario
      • 8.4.6.3. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.7. Norway
      • 8.4.7.1. Key country dynamics
      • 8.4.7.2. Competitive scenario
      • 8.4.7.3. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key country dynamics
      • 8.4.8.2. Competitive scenario
      • 8.4.8.3. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.9. Denmark
      • 8.4.9.1. Key country dynamics
      • 8.4.9.2. Competitive scenario
      • 8.4.9.3. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Competitive scenario
      • 8.5.2.3. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Competitive scenario
      • 8.5.3.3. China market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Competitive scenario
      • 8.5.4.3. India market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.5. Australia
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Competitive scenario
      • 8.5.5.3. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.6. South Korea
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Competitive scenario
      • 8.5.6.3. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.7. Thailand
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Competitive scenario
      • 8.5.7.3. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Competitive scenario
      • 8.6.2.3. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Competitive scenario
      • 8.6.3.3. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Competitive scenario
      • 8.7.2.3. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Competitive scenario
      • 8.7.3.3. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Competitive scenario
      • 8.7.4.3. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key country dynamics
      • 8.7.5.2. Competitive scenario
      • 8.7.5.3. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2023
  • 9.4. Company Profiles/Listing
    • 9.4.1. Merck KGaA
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product/Service benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. QIAGEN
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product/Service benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Thermo Fisher Scientific, Inc.
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product/Service benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Takara Bio
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product/Service benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Promega Corporation
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product/Service benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Zymo Research
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product/Service benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. MP BIOMEDICALS
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product/Service benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. New England Biolabs
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product/Service benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. MCLAB
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product/Service benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Applied Biological Materials, Inc.
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product/Service benchmarking
      • 9.4.10.4. Strategic initiatives